tradingkey.logo

BRIEF-Data From A Long-Term Follow-Up Study To The Olympus Trial Published In The Journal Of Urology

ReutersFeb 12, 2025 1:03 PM

- Urogen Pharma UR8.F:

  • DATA FROM A LONG-TERM FOLLOW-UP STUDY TO THE OLYMPUS TRIAL THAT SHOWS A MEDIAN DURATION OF RESPONSE OF NEARLY FOUR YEARS IN PATIENTS ACHIEVING COMPLETE RESPONSE WITH JELMYTO PUBLISHED IN THE JOURNAL OF UROLOGY

Source text: ID:nBw3MmwsWa

Further company coverage: UR8.F

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI